{"title":"评估使用高流量鼻氧治疗的 COVID-19 住院患者中新提出的 ARDS 定义。","authors":"Shahin Isha, Gustavo Olaizola, Indalecio Carboni Bisso, Lekhya Raavi, Sadhana Jonna, Anna Jenkins, Abby Hanson, Rahul Kashyap, Veronica Monzon, Ivan Huespe, Devang Sanghavi","doi":"10.4187/respcare.11933","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> among non-intubated subjects with ARDS.</p><p><strong>Methods: </strong>This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 315 [with S<sub>pO<sub>2</sub></sub> ≤ 97%] or a P<sub>aO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 300 mm Hg while receiving ≥30 L/min O<sub>2</sub> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> cutoff proposed in the new ARDS definition, and mortality.</p><p><strong>Results: </strong>Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (<i>n =</i> 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (<i>n</i> = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (<i>n</i> = 98). Additionally, the worst S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (<i>n =</i> 177) for subjects with S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 148, 17% (95% CI 12-23) (<i>n =</i> 38) for those with S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> between 149-234, and 16% (95% CI 8-28) (<i>n =</i> 10) for subjects maintaining an S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> higher than 235 (<i>P</i> < .001).</p><p><strong>Conclusions: </strong>The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen.\",\"authors\":\"Shahin Isha, Gustavo Olaizola, Indalecio Carboni Bisso, Lekhya Raavi, Sadhana Jonna, Anna Jenkins, Abby Hanson, Rahul Kashyap, Veronica Monzon, Ivan Huespe, Devang Sanghavi\",\"doi\":\"10.4187/respcare.11933\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> among non-intubated subjects with ARDS.</p><p><strong>Methods: </strong>This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 315 [with S<sub>pO<sub>2</sub></sub> ≤ 97%] or a P<sub>aO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 300 mm Hg while receiving ≥30 L/min O<sub>2</sub> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> cutoff proposed in the new ARDS definition, and mortality.</p><p><strong>Results: </strong>Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (<i>n =</i> 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (<i>n</i> = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (<i>n</i> = 98). Additionally, the worst S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (<i>n =</i> 177) for subjects with S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> ≤ 148, 17% (95% CI 12-23) (<i>n =</i> 38) for those with S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> between 149-234, and 16% (95% CI 8-28) (<i>n =</i> 10) for subjects maintaining an S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> higher than 235 (<i>P</i> < .001).</p><p><strong>Conclusions: </strong>The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<sub>pO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.</p>\",\"PeriodicalId\":21125,\"journal\":{\"name\":\"Respiratory care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4187/respcare.11933\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4187/respcare.11933","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen.
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the SpO2 /FIO2 among non-intubated subjects with ARDS.
Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an SpO2 /FIO2 ≤ 315 [with SpO2 ≤ 97%] or a PaO2 /FIO2 ≤ 300 mm Hg while receiving ≥30 L/min O2 via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the SpO2 /FIO2 cutoff proposed in the new ARDS definition, and mortality.
Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst SpO2 /FIO2 within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with SpO2 /FIO2 ≤ 148, 17% (95% CI 12-23) (n = 38) for those with SpO2 /FIO2 between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an SpO2 /FIO2 higher than 235 (P < .001).
Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The SpO2 /FIO2 and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
期刊介绍:
RESPIRATORY CARE is the official monthly science journal of the American Association for Respiratory Care. It is indexed in PubMed and included in ISI''s Web of Science.